Valeant Stock Price (NYSE:VRX)

Add to My Stocks
$16.35 $0.05 (0.3%) VRX stock closing price Feb 22, 2017 (Closing)
21 FEB 2017
amigobulls logo
VRX hand_up
VRX vs S&P 500
Closing Price: Feb 21, 2017
$16.4 ( 2.24%)
S&P 500
2365.4 ( 0.6%)
52 Week Price Range
1 Year Return: -78.87%
Q3 Growth*
Profitable ?
net image
2016 Q3 Net Loss
PE Valuation
home image
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen

Valeant Snapshot Video

34 5 2

VRX Stock Details

Prev Close* : $16.40
Market Cap:
Day Low: $16.33
52 Week Low: $13.00
Open: $16.34
Volume: 9695397
Day High: $16.82
52 Week High: $86.55

Valeant Stock Articles & Video

more news on VRX stock

Valeant News - From Partners

VRX Stockcharts

View VRX PE ratio, PS ratio stocks charts and compare with peers.
VRX Chart
Note: Compare Valeant stock price history with the index and industry peers.

Valeant Valuation

PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Valeant Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity

VRX Industry Peers

Company Price Change (%)
Questcor Pharma (QCOR)93.61.52 (1.65%)
Ionis Pharma (IONS)46.20.74 (1.58%)
Glaxosmithkline (GSK)41.030.6 (1.44%)
Novartis (NVS)76.850.19 (0.25%)
Johnson & Johnson (JNJ)119.520.14 (0.12%)
Pfizer (PFE)33.590.03 (0.09%)
Astrazeneca (AZN)28.920.09 (0.31%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Depomed (DEPO)17.251.48 (9.38%)
Achaogen (AKAO)23.621.07 (4.75%)
Zogenix (ZGNX)10.850.35 (3.33%)
Corcept Therapeutics (CORT)8.510.27 (3.28%)
Aralez Pharma (ARLZ)4.580.08 (1.78%)
Ignyta (RXDX)9.250.15 (1.65%)
Lannett Co (LCI)22.850.3 (1.33%)
Top gainers from Medical-Drugs industry
* As of Feb 22, 2017
CompanyPriceChange (%)
United Therapeutics (UTHR)146.9820.94 (12.47%)
ChemoCentryx (CCXI)6.550.62 (8.65%)
Esperion Therapeutics (ESPR)22.531.89 (7.74%)
La Jolla Pharma (LJPC)16.971.12 (6.19%)
Xencor (XNCR)23.41.13 (4.61%)
CTI BioPharma (CTIC)4.280.18 (4.04%)
BioCryst Pharma (BCRX)5.860.24 (3.93%)
Top losers from Medical-Drugs industry
* As of Feb 22, 2017

Valeant Financial Statements

income statement20152014201320122011
Net Sales Or Revenues10.45B8.26B5.77B3.55B2.46B
Net Income-291.7M913.5M-866.14M-116.02M159.55M
Total Operating Expense6.33B3.97B4.27B2.43B1.44B
view Valeant Pharmaceuticals Intl Inc income statement
balance sheet20152014201320122011
Total Assets48.96B26.35B27.97B17.95B13.14B
Total Liabilities42.93B20.92B22.74B14.23B9.13B
Shareholders Equity6.03B5.43B5.23B3.72B4.01B
view Valeant Pharmaceuticals Intl Inc balance sheet
cash flow statement20152014201320122011
Net Increase (Decrease) In Assets Liabilities-822.2M-668.4M-378.29M-253.27M-132.97M
Net Cash From (Used By) Operating Activities2.2B2.29B1.04B656.57M676.47M
Increase (Decrease) In Prop Plant And Equipment-222.4M1.2B-74.22M-15.64M-58.51M
view Valeant Pharmaceuticals Intl Inc cashflow statement

Valeant Pharmaceuticals Intl Inc Stock News - Partner Headlines

Valeant Stock Message Board

Valeant stock price ended the last trading day at 16.4. Looking at Valeant market capitalization, which currently stands at 5.47B, we can say that VRX stock is a Mid cap stock. Valeant valuation can be guaged using various valuation metrics like the price to earnings ratio.

For recognizing and analyzing the real performance of Valeant stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. The volume number in Valeant stock quote data shows the number of shares traded. For Ex: 9435692 Valeant shares were traded as of last trading day, as seen from Valeant stock chart. The board of directors decide what percentage of a company's earnings will be paid out as dividends. One can observe stock price trends and check for volatility by checking Valeant stock price history.